{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:42:04Z","timestamp":1788856924801,"version":"build-2803163510"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate pain reduction after two injections of 50 units botulinum toxin A compared with placebo for provoked vestibulodynia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We conducted a double-blinded, placebo-controlled randomized trial of 50 units botulinum toxin A or placebo injected in the bulbocavernosus muscles twice, 3 months apart, in women with provoked vestibulodynia. Primary outcome was self-reported dyspareunia or pain at tampon use on a visual analog scale (VAS, 0\u2013100). Secondary outcomes were pain at weekly tampon insertion (VAS score), reduction of pelvic floor hypertonicity (measured with a vaginal manometer), adverse events, and sexual function and distress. A sample size of 38 participants for each group was calculated to achieve a statistical power of 80% based on an effect size of 20 VAS units (0\u2013100) (mean score range 56\u201376\u00b131 SD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Between May 2016 and June 2018, 124 women with provoked vestibulodynia were assessed, and 88 were randomized to botulinum toxin A (BTA group, n=44) or placebo (placebo group, n=44). Primary outcome showed a lower but statistically nonsignificant pain rating by 7 VAS units (95% CI \u221215.0 to 0.4) in the BTA group compared with the placebo group. Secondary results showed a significant decrease in pain at weekly tampon insertion by 11 VAS units (95% CI \u221216.6 to 6.0) with botulinum toxin A injection. The vaginal manometer measured lower maximum contraction strength by 7 mm Hg (95% CI \u221212.7 to \u22122.4) and lower 10-second endurance strength by 4 mm Hg (95% CI \u22127.72 to \u22121.16) in the BTA group compared with the placebo group. No changes were observed for sexual function and distress, but there was a significant increase in women attempting vaginal intercourse in the BTA group (0.27, 95% CI 0.06\u20130.48). No severe adverse events were reported.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Twice-repeated injections of 50 units of botulinum toxin A in women with provoked vestibulodynia did not reduce dyspareunia or pain at tampon use, but secondary outcomes suggested positive effects of the treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n            <jats:p>ClinicalTrials.gov, NCT02773641.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000004008","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T16:00:27Z","timestamp":1596729627000},"page":"524-532","source":"Crossref","is-referenced-by-count":30,"title":["Botulinum Toxin A as a Treatment for Provoked Vestibulodynia"],"prefix":"10.1097","volume":"136","author":[{"given":"Philip","family":"Haraldson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"M\u00fchlrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Heddini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Bohm-Starke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"R1-20230713","first-page":"82","article-title":"A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia?","volume":"58","author":"Harlow","year":"2003","journal-title":"J Am Med Womens Assoc"},{"key":"R2-20230713","doi-asserted-by":"crossref","first-page":"170.e1","DOI":"10.1016\/j.ajog.2011.08.012","article-title":"Prevalence and demographic characteristics of vulvodynia in a population-based sample","volume":"206","author":"Reed","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20230713","first-page":"223","article-title":"The evidence-based vulvodynia assessment project. A national registry for the study of vulvodynia","volume":"60","author":"Lamvu","year":"2015","journal-title":"J Reprod Med"},{"key":"R4-20230713","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jsxm.2015.12.021","article-title":"Vulvodynia: definition, prevalence, impact, and pathophysiological factors","volume":"13","author":"Pukall","year":"2016","journal-title":"J Sex Med"},{"key":"R5-20230713","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/jsm.12213","article-title":"Sexual and relationship satisfaction and vestibular pain sensitivity among women with provoked vestibulodynia","volume":"10","author":"Smith","year":"2013","journal-title":"J Sex Med"},{"key":"R6-20230713","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.pain.2014.05.010","article-title":"Vulvodynia: current state of the biological science","volume":"155","author":"Wesselmann","year":"2014","journal-title":"Pain"},{"key":"R7-20230713","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000010045","article-title":"Increased intraepithelial innervation in women with vulvar vestibulitis syndrome","volume":"46","author":"Bohm-Starke","year":"1998","journal-title":"Gynecol Obstet Invest"},{"key":"R8-20230713","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jpain.2016.12.008","article-title":"A local inflammatory renin-angiotensin system drives sensory axon sprouting in provoked vestibulodynia","volume":"18","author":"Liao","year":"2017","journal-title":"J Pain"},{"key":"R9-20230713","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jsxm.2017.02.012","article-title":"Heightened pelvic floor muscle tone and altered contractility in women with provoked vestibulodynia","volume":"14","author":"Morin","year":"2017","journal-title":"J Sex Med"},{"key":"R10-20230713","doi-asserted-by":"crossref","first-page":"751.e1","DOI":"10.1016\/j.ajog.2016.06.047","article-title":"Relationship between nongenital tender point tenderness and intravaginal muscle pain intensity: ratings in women with provoked vestibulodynia and implications for treatment","volume":"215","author":"Phillips","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230713","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00192-015-2660-6","article-title":"Pelvic floor muscle function in women with provoked vestibulodynia and asymptomatic controls","volume":"26","author":"Naess","year":"2015","journal-title":"Int Urogynecol J"},{"key":"R12-20230713","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.ogx.0000219814.40759.38","article-title":"A conceptual model for the pathophysiology of vulvar vestibulitis syndrome","volume":"61","author":"Zolnoun","year":"2006","journal-title":"Obstet Gynecol Surv"},{"key":"R13-20230713","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00126839-200809010-00002","article-title":"Botulinum toxin for pain","volume":"9","author":"Casale","year":"2008","journal-title":"Drugs R D"},{"key":"R14-20230713","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejogrb.2018.12.013","article-title":"Botulinum toxin-treatment of localized provoked vulvodynia refractory to conventional treatment","volume":"234","author":"Hedebo Hansen","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R15-20230713","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/j.1743-6109.2009.01378.x","article-title":"Botulinum toxin type A-a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study","volume":"6","author":"Petersen","year":"2009","journal-title":"J Sex Med"},{"key":"R16-20230713","first-page":"467","article-title":"Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label, pilot study","volume":"51","author":"Dykstra","year":"2006","journal-title":"J Reprod Med"},{"key":"R17-20230713","first-page":"617","article-title":"Efficacy of high doses of botulinum toxin A for treating provoked vestibulodynia","volume":"164","author":"Pelletier","year":"2011","journal-title":"Br J Dermatol"},{"key":"R18-20230713","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"R19-20230713","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00926230590475206","article-title":"The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores","volume":"31","author":"Wiegel","year":"2005","journal-title":"J Sex Marital Ther"},{"key":"R20-20230713","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/00926230290001448","article-title":"The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women","volume":"28","author":"Derogatis","year":"2002","journal-title":"J Sex Marital Ther"},{"key":"R22-20230713","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00404-019-05043-w","article-title":"Subcutaneous botulinum toxin type A injections for provoked vestibulodynia: a randomized placebo-controlled trial and exploratory subanalysis","volume":"299","author":"Diomande","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"R23-20230713","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/AOG.0b013e31819bda7c","article-title":"The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness","volume":"113","author":"Foster","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R24-20230713","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/AOG.0000000000002617","article-title":"Gabapentin for the treatment of vulvodynia: a randomized controlled trial","volume":"131","author":"Brown","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R25-20230713","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/srt.12010","article-title":"An in vivo analysis of the effect and duration of treatment with botulinum toxin type A using digital image speckle correlation","volume":"19","author":"Bhatnagar","year":"2013","journal-title":"Skin Res Technol"},{"key":"R26-20230713","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/11530110-000000000-00000","article-title":"Botulinum toxin","volume":"11","author":"Flynn","year":"2010","journal-title":"Am J Clin Dermatol"},{"key":"R27-20230713","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2340\/00015555-2093","article-title":"Regional diffusion of botulinum toxin in facial muscles: a randomised double-blind study and a consideration for clinical studies with split-face design","volume":"95","author":"Punga","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"R28-20230713","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.apmr.2015.01.010","article-title":"Single-fiber electromyography analysis of botulinum toxin diffusion in patients with fatigue and pseudobotulism","volume":"96","author":"Ruet","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"R29-20230713","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1743-6109.2011.02270.x","article-title":"Intralevator injection of botulinum toxin for the treatment of hypertonic pelvic floor muscle dysfunction and vestibulodynia","volume":"8","author":"Goldstein","year":"2011","journal-title":"J Sex Med"},{"key":"R30-20230713","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/LGT.0000000000000406","article-title":"Systematic review of treatment outcome measures for vulvodynia","volume":"22","author":"Sadownik","year":"2018","journal-title":"J Lower Genital Tract Dis"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T17:07:50Z","timestamp":1689268070000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004008"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004008","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,5]]}}}